Eng

Proviron

Quick links to important sections

Proviron

Selected form

Mesterolone

Method of action: Androgenic, Sex Hormones And Modulators Of The Genital System

Treatment option: Anemia, Infertility, Hypogonadism

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proviron

Quick Facts

Property	Description
Active Ingredient	Mesterolone (INN)
Form	Oral tablet
Pharmacological Class	Androgen
General Purpose	Hormone replacement therapy (male)
Origin	Synthetic steroid, Dihydrotestosterone (DHT) derivative

What is Proviron (Mesterolone)?

Proviron, containing the active substance Mesterolone, is a prescription-only medicine classified as a synthetic androgen, utilized for hormone replacement in men. It is an orally active steroid designed to substitute for or supplement naturally low levels of male hormones. Mesterolone is a chemically modified derivative of the potent endogenous hormone dihydrotestosterone (DHT), which is essential for its strong androgenic activity.

Proviron belongs to the pharmacological class of androgenic hormonal agents. It possesses a high affinity for the androgen receptor, placing it among the agents recognized for managing conditions related to male hormonal balance and insufficiency.

Composition and Unique Formulation as an Oral Tablet

The composition of the pharmaceutical preparation Proviron centers entirely on the single active ingredient Mesterolone, delivered in a solid tablet form. This design makes Proviron an oral medication intended for convenient ingestion.

Structurally, Mesterolone is unique among oral androgens because it is non-aromatizable—a property that prevents its conversion into estrogen within the body. Furthermore, its design avoids the 17alpha-alkylation found in many other orally administered steroids. This unique formulation is clinically recognized for providing the necessary bioavailability for therapeutic effect without the specific hepatic challenges often associated with that structural modification.

What is the General Purpose of Proviron?

The general purpose of Proviron is to serve as an androgen replacement therapy, primarily in the context of male androgen deficiency or male hypogonadism. By acting as a direct androgen receptor agonist, Mesterolone helps to restore the overall hormonal equilibrium in adult men experiencing insufficient natural androgen production.

This targeted hormone replacement action is essential for maintaining or re-establishing the proper function of tissues and processes reliant on adequate levels of male hormones, fulfilling its primary role in maintaining necessary male hormonal balance.

What side effects are possible with Proviron?

Possible Side Effects and Safety Information

The official safety profile for Mesterolone (Proviron) is structured around documented risks associated with its action as an androgen, emphasizing effects on hormone-sensitive systems and potential rare, serious systemic risks. Safety classifications are based on governmental regulatory documents.

Documented Adverse Reactions

The most consistently classified adverse reaction is the occurrence of frequent or persistent erections, which is designated as common in regulatory documentation. This may necessitate temporary dose adjustment or cessation of treatment. Other adverse effects are grouped according to System-Organ Classes (SOCs):

SOC Category	Officially Documented Effects
Reproductive System	Prostatic enlargement (BPH), frequent/persistent erections.
Skin Disorders	Acne, hair loss, or excessive hairiness.
Psychiatric Disorders	Depression, increased aggressiveness, and headache.

Serious Safety Considerations

The regulatory label highlights the potential for serious adverse reactions, particularly those affecting the liver. These documented risks include the possibility of benign and malignant hepatic tumours (liver tumors) and peliosis hepatis, which are often noted without a specific frequency classification. Due to its mechanism, Mesterolone is contraindicated in men with known or suspected prostate carcinoma or a history of hepatic tumours.

Population-Specific Safety Notes

For older adults, the official labeling mandates regular prostate monitoring which includes digital rectal examinations and serum Prostate-Specific Antigen (PSA) testing. This vigilance is required particularly during periods of long-term exposure to monitor for potential prostatic changes. Regulatory documents explicitly advise that Mesterolone should not be used by healthy individuals for non-therapeutic purposes like enhancing physical ability.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for mesterolone indicates a low acute toxicity risk from a single, isolated overdosage, with no reports of ill-effects following acute ingestion. However, the product labeling highlights serious long-term risks associated with the excessive or prolonged use of hormonal substances.

Documented Risks and Emergency Actions

Classification	Official Regulatory Statement
Chronic Overexposure	Excessive use is associated with systemic manifestations, including liver abnormalities, tumours, changes to blood lipids, decreased testosterone levels, and an increased risk of heart disease.
Antidote Status	No specific antidote is known for mesterolone; management for acute intoxication is limited to supportive care.
Urgent Action Mandate	You must immediately telephone a doctor, contact the Poisons Information Centre, or go to the Accident and Emergency department at the nearest hospital.
Help-Seeking Trigger	Urgent medical attention is required for a suspicion of taking too much, even in the absence of obvious symptoms.

If the overdosage is confirmed within two to three hours, regulatory sources note that gastric lavage may be safely used if deemed necessary by a medical professional. Population-specific considerations include an elevated risk of prostatic hyperplasia and prostatic cancer in men over 65 with overexposure, and a risk of stunted growth if used before the end of puberty.

Therapeutic Uses of Proviron

What Proviron Treats: Main Uses and Benefits

The therapeutic application of Mesterolone is generally used as a substitution therapy for a clinically established androgen deficiency in men. The medication is used to replace testosterone in men with hypogonadism. The drug is relevant across conditions where symptoms arise directly from insufficient endogenous male hormone production, providing support to three main domains of patient function.

The therapeutic domain is relevant for managing male hypogonadism, whether the condition is congenital or acquired. It is applied in addressing the pervasive symptoms that result from the loss of gonadal function. This includes symptom clusters related to easy fatigability, mental alertness, libido, and potency. This supportive use may help patients cope more steadily with the chronic manifestations of hormonal loss.

The medication is applied in clinical settings where symptoms are considered relevant to the underlying deficiency, and this supportive action may assist with reducing the overall symptom burden. It is also relevant for specific contexts of male subfertility or oligozoospermia where hormonal factors are a component. This application can contribute to improved comfort and functional stability, particularly in middle- and old-aged men.

Quick Fact: Relief for Androgen Deficiency Symptoms
Main Use: Substitution therapy for clinically established androgen deficiency and hypogonadism in men.
Symptom Cluster: Addresses symptoms related to systemic imbalance, including fatigue, mood issues, and sexual function disturbances.

Regulatory References

Australian NPS MedicineWise overview of Proviron

Eligibility and Restrictions for Use

Eligibility Scope

Proviron (mesterolone) is a prescription medicine strictly indicated for adult male patients with clinically established androgen deficiency (hypogonadism) or certain hormonal-related forms of male infertility.

Status	Population Exclusion (Contraindicated)
Absolute Ban	Individuals with prostate cancer, male breast cancer, previous or existing liver tumours, or hypercalcaemia must not use this medication. The medicine is also prohibited for women, children, and those with a known allergy to its components, including specific genetic lactose intolerances.

Status	Conditional Use (Requires Monitoring)
Special Caution	Use requires special caution and close medical monitoring for patients with hypertension, cardiovascular disease, epilepsy, migraine, diabetes, or prostatic hyperplasia (BPH).

Official Eligibility Statements

The medication is exclusively for use in adult males and is not recommended for the pediatric population (children and adolescents).
Use in older adults carries an increased risk of prostatic issues, mandating regular examinations of the prostate.
The use is conditional for patients with specific cardiovascular or metabolic comorbidities, necessitating ongoing medical oversight.

Connection to the Overall Eligibility Profile

Official regulatory documents define the eligibility profile of Proviron through mandatory oncological exclusions and a strict gender/age limitation. This profile establishes an absolute prohibition for certain high-risk groups while requiring rigorous clinical monitoring for patients with specific pre-existing conditions, thereby defining who can or cannot use the medicine based on label-specified restrictions.

What should I know about interactions with other medicines?

Proviron Interactions with other medicines and products

Proviron (mesterolone) may interact with several types of medicines, potentially altering their effects or increasing the risk of adverse reactions. It is crucial to inform your healthcare provider about all prescription, over-the-counter, and herbal supplements you are currently taking before starting Proviron treatment.

Key Drug Interactions

Drug Class	Potential Interaction Effect
Anticoagulants (e.g., Warfarin)	Proviron may enhance the effect of these blood thinners, increasing the risk of bleeding. The dosage may need adjustment.
Oral Antidiabetics/Insulin	Proviron may improve glucose tolerance and reduce the need for these medications in some diabetic patients. Close blood sugar monitoring is required.
Corticosteroids	Concurrent use may increase the risk of edema (fluid retention), particularly in patients with pre-existing heart or liver disease.
Hepatic Enzyme Inducers/Inhibitors	Medicines that affect liver enzymes (e.g., rifampicin, phenobarbital) may alter Proviron's metabolism and blood levels.

Additional Considerations

The effects of alcohol on Proviron's metabolism are not fully established, but it is generally advisable to limit consumption. Regular laboratory monitoring, including liver function tests and prostate-specific antigen (PSA) levels, may be necessary during treatment.

Mechanism of Action

Proviron (mesterolone) is a synthetic androgen that functions across several mechanistic domains to modulate hormonal signaling and systemic physiology.

Androgen Receptor Agonism

As a derivative of dihydrotestosterone (DHT), mesterolone acts as an agonist by binding to and activating androgen receptors (AR) in target cells. This engagement initiates intracellular signaling sequences that modify the transcription of specific genes, thereby regulating the expression of proteins associated with androgenic differentiation and cellular activity.

Modulation of Sex Hormone-Binding Globulin (SHBG)

Proviron exhibits a high affinity for SHBG, a plasma glycoprotein that binds and inactivates testosterone. By binding strongly to SHBG, mesterolone effectively displaces endogenous testosterone. This action increases the concentration of free, biologically active testosterone in the circulation, which consequently alters the free-to-bound ratio of the circulating androgen pool.

Resistance to Aromatization

An intrinsic property of mesterolone is its resistance to the aromatase enzyme. It is not a substrate for aromatase, preventing its conversion into estrogenic metabolites. This mechanism maintains the circulating androgen profile without increasing estrogenic activity.

Dosage and Administration Information

Instruction Map: How to Use Proviron — Administration Guidelines

This map details the standard procedures for administering mesterolone, based on standard prescribing documentation.

Administration Scope

Feature	Detail
Route of administration:	Oral administration only.
Dosing schedule:	The starting dose for conditions like declining activity is typically 75 mg daily, which is then reduced to a maintenance dose of 25 mg to 50 mg daily.
Timing in relation to meals (if applicable):	The tablet should be swallowed whole with water, and labeling states that the time relative to meals does not matter.
Age-group administration rules:	The instructions are established for use in adult men; explicit numerical dose adjustments for older adults or renal impairment are not typically detailed in prescribing documentation.
Special procedural conditions:	Treatment for hypogonadism is defined as continuous therapy (long-term use), whereas treatment for oligozoospermia is administered in a specific 90-day cycle.

Instruction Classifications (High-Level)

Classification	Detail
Administration method type:	Oral
Frequency pattern:	Divided daily use, typically one to three times per day.
Basis of use:	Standard pharmaceutical documentation.
Use-context constraints:	When administered at the recommended dose, mesterolone will not impair spermatogenesis (sperm production).

Resulting Procedural Structure

Standard step sequence:

Take the tablet orally: Ingest the 25 mg tablet whole with water.
Divide the daily dose: Administer the prescribed total daily dose across one to three separate times.
Maintain duration: Continue use as either a continuous, long-term replacement or for the defined short-term cycle.

Connection to the overall use protocol: The use protocol is structured around the oral tablet form, requiring a divided daily frequency to ensure consistent exposure to the active substance. The regimen mandates a higher initial dose that transitions to a lower maintenance dose, and the overall treatment duration follows either a specific cyclic pattern or continuous use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Proviron

Proviron, containing Mesterolone, was evaluated in research exploring two main clinical situations where male hormone balance is a factor: androgen deficiency symptoms and specific types of male subfertility. The research describes the patterns observed in men using this medicine, providing context on what has been observed and where the evidence remains limited.

Evidence for Use in Androgen Deficiency and Male Hypogonadism Symptoms

Research has explored Mesterolone in the context of androgen deficiency in adult men experiencing symptoms related to low natural male hormone production, a condition known as hypogonadism. Randomized Controlled Trials (RCTs) and various observational studies were applied in studies examining patient-reported experiences in these populations.

The primary outcomes used in research exploring how symptoms change over time that were monitored included changes in sexual function scores, specifically covering libido and erectile function. Researchers also used in research exploring how symptoms change over time related to mental and psychological metrics, such as feelings of fatigue, mental alertness, and mood. Findings describe patterns observed in the studies concerning changes in these symptom scores. When Mesterolone was evaluated in comparative studies against other androgen forms, data show patterns related to differences in the changes reported for these specific functions.

Evidence for Use in Male Subfertility (Oligozoospermia)

Research explored Mesterolone in a specific context of male subfertility known as oligozoospermia, where low sperm concentration is a factor. The research structure included Randomized Double-Blind Studies and long-term cohort clinical trials. The study outcomes examined centered on semen characteristics, including detailed measurements of sperm count, sperm motility, and morphology.

The findings were mixed across different randomized trials when assessing changes in sperm concentration and motility. Data show patterns related to inconsistency in reported outcomes for semen parameters and partner pregnancy rates. Certainty remains low for this application according to some analyses, and research exploring comparisons with other standard preparations is limited in some areas.

Key Studies & References

How should Proviron be stored and disposed of?

Storage and Disposal of Proviron (Mesterolone)

Proviron tablets must be stored according to specific regulatory conditions to maintain stability.

Official Storage Requirements

Condition	Requirement
Temperature	Store below 30°C and protect from heat
Protection	Protect from dampness and avoid locations like bathrooms or cars
Packaging	Keep in the original package (blister pack) until use
Safety	Keep out of the sight and reach of children

Official Disposal Rules

Expired or unused Proviron must not be disposed of in household waste or wastewater. The medication should be returned to a pharmacist for proper environmental disposal. Do not use the tablets after the expiry date printed on the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.